Product Information
Name:ST1326
Brand:Biosynth
Description:ST1326 is a carnitine-based compound that has been shown to exhibit anti-cancer activity. It was found to reduce the mitochondrial membrane potential in prostate cancer cells, as well as inhibit the growth of these cells. ST1326 also reduces the expression of an amp-activated protein kinase, which can lead to apoptosis, and inhibits transcriptional regulation. ST1326 has also been shown to have a direct effect on cervical cancer by inhibiting the phosphorylation of c-Jun N-terminal kinase (JNK) and reducing its downstream signaling pathways. This drug binds to fatty acids and can be used for the treatment of diabetic patients with congestive heart failure.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:399.61 g/mol
Formula:C22H45N3O3
Purity:Min. 95%
Technical inquiry about: ST1326
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.